North Star Investment Management Corp. Oncternal Therapeutics, Inc. Transaction History

North Star Investment Management Corp.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	BUY	$0.29 - $0.48 $1,450 - $2,400	5,000 Added 100.0%	10,000 $3,000
Q4 2020 Jan 12, 2021	BUY	$1.51 - $6.3 $1,510 - $6,300	1,000 Added 25.0%	5,000 $24,000
Q1 2020 Apr 23, 2020	SELL	$2.49 - $4.39 $2,241 - $3,950	-900 Reduced 18.37%	4,000 $12,000
Q3 2019 Oct 03, 2019	BUY	$3.87 - $6.13 $18,963 - $30,037	4,900 New	4,900 $24,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

Stay updated on North Star Investment Management Corp. with notifications on news.